Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Iris Maria Forte

6PUBLICATIONS

26CO-AUTHORS

Cancer cell biologyMolecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Sep 13, 2025

NONO Protein Regulates the Immune Response in Human Triple-Negative Breast Cancer Cells.

Carmelina Antonella Iannuzzi, Iris Maria Forte, Marianna Tomeo

|Jan 08, 2025

Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell Death.

Giulio Mazzarotti, Maria Cuomo, Maria Carmen Ragosta

|Dec 28, 2021

The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach.

Iris Maria Forte, Paola Indovina, Serena Montagnaro

|Oct 06, 2020

Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the <i>dl922-947</i> Oncolytic Virus in Malignant Mesothelioma Cell Lines.

Carmelina Antonella Iannuzzi, Paola Indovina, Iris Maria Forte

|Aug 29, 2020

HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis.

Pierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli

|Nov 10, 2018

Caprine herpesvirus 1 (CpHV-1) as a potential candidate for oncolytic virotherapy.

Serena Montagnaro, Sara Damiano, Roberto Ciarcia

Pageof 1

Frequent Collaborators

5 joint publications

Antonio Giordano

2 joint publications

Serena Montagnaro

2 joint publications

Carmelina Antonella Iannuzzi

2 joint publications

Rosa Camerlingo

2 joint publications

Michelino De Laurentiis

2 joint publications

Francesca Pentimalli

2 joint publications

Anna Maria Malfitano

1 joint publications

Roberto Ciarcia

1 joint publications

Valentina Iovane

1 joint publications

Ugo Pagnini

Frequent Collaborators

5 joint publications

Antonio Giordano

2 joint publications

Serena Montagnaro

2 joint publications

Carmelina Antonella Iannuzzi

2 joint publications

Rosa Camerlingo

Top Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on : Jul 20, 2019

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs <em>In Vitro</em> and Their Determination by <sup>32</sup>P-postlabeling

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs <em>In Vitro</em> and Their Determination by <sup>32</sup>P-postlabeling

Published on : Mar 20, 2018

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

See more related videos

Top Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on : Jul 20, 2019

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs <em>In Vitro</em> and Their Determination by <sup>32</sup>P-postlabeling

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs <em>In Vitro</em> and Their Determination by <sup>32</sup>P-postlabeling

Published on : Mar 20, 2018

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

See more related videos